Frank (Chip) Brosius: Dr. Brosius joined the University of Arizona in 2017 from the University of Michigan where he was the Division Director for Nephrology. Dr. Brosius is one of the country’s leading experts in Diabetic Kidney disease and directed the University of Michigan’s O’Brien center (one of only seven such centers nationwide). Chip is currently an active member of the Arizona Kidney and Vascular center and involved in translational and clinical research (see below) in both vascular access and diabetic kidney disease. Dr. Brosius is funded through the NIH.
Bijin Thajudeen: Dr. Thajudeen’s main interests are in Acute Kidney Injury and Telemedicine. He is actively involved in the clinical research activities of the Division and is the site PI for a study on CRRT in the ICU.
Sangeetha Murugapandian: Dr. Murugapandian is dual board eligible in both nephrology and Geriatrics. She recently joined the faculty from the University of Louisville and is developing a research program in fraility in collaboration with Geriatric Medicine.
Gabriel El-Kass: Dr. El-Kass is an interventional nephrologist who is actively involved in a translational research project to identify predictors of vascular access success and failure.
Rick Schnellman: Dr. Schnellman is the Dean of the College of Pharmacy (top 10 ranking nationally) and leads an internationally renowned program on drug development for acute kidney injury. Dr. Schnellman is funded through NIH and VA grants.
Heddwen Brooks: Dr. Brooks’ main research interests are in sex differences in hypertension and the role of vasopressin in renal cell proliferation. Dr. Brooks is funded through the NIH and the state of Arizona.